ISoOR Insight Team. “Genmab Acquires Merus for $8 Billion: The First Organoid-Discovered Clinical Asset Drives the Largest European Oncology Deal of 2025”. Journal of Organoid and Bioscience, vol. 3, no. 1, Mar. 2026, https://jobs.isoor.org/index.php/journal/article/view/57.